Leadership Change

Arch Insurance promotes Nora Deveau to Chief Claims Officer, a move signaling a deep commitment to internal talent and strategic stability for the critical unit.

Facing a cash crunch and delisting threat, ENvue Medical stacks its board with clinical, AI, and finance heavyweights. Is it a lifeline or a last-ditch effort?

Slate Medicines appoints Mark W. Hahn, a CFO known for steering biotechs to massive acquisitions, signaling a major strategic push for its next-gen therapy.

With a Parkinson's therapy in hand and a universal AI model, Cellular Intelligence adds seasoned leaders to turn biological ambition into durable value.

A construction firm's radical shift to critical minerals, guided by a military strategist, reveals a new front in the race for America's resource security.

As Corrixr's novel CRISPR therapy nears human trials, the appointment of Seagen veteran Nancy Whiting signals a strategic shift from lab to market.

As cyber threats escalate, one company's record growth reveals a market shift: CISOs no longer want more data; they need smarter answers. Here's the why.

As rivals consolidate, Holmes Murphy doubles down on independence, promoting a 24-year veteran in a calculated move to secure its future.

With the hire of COO Ainslie Little, Flagship-backed ProFound Therapeutics signals a strategic shift from pure discovery to operational scale-up.

iQuanti appoints Jonathan Gagliano as Chief Growth Officer, a strategic move to master AI-driven marketing as LLMs dismantle traditional consumer journeys.

Veteran dealmaker Meron Raz takes the helm at AI startup Iron Brain, a strategic play by Cortica to catapult Israel's defense-tech onto the global stage.

With three veteran execs and an agentic AI strategy, Genesis Automation is betting big on unifying the fragmented hospital supply chain. Is this the future?

Laird Superfood's CFO is stepping down after a period of major acquisitions. Is this a planned transition or a symptom of the company's growing pains?

With new launches in Austin and Cleveland and a C-suite of Tesla, Waymo, and Uber vets, Zipline is rapidly scaling its autonomous delivery empire.

With deep expertise in high-growth healthcare niches, Aaron Newman's move to Cascade Partners signals a strategic expansion amid a complex M&A market.

Ellavoz Impact Capital's CEO transition is more than a new name on the door. It's a blueprint for how mission-driven firms are scaling to tackle America's housing crisis.

With industry pioneer Michael Rigas on board, Infusion for Health's expansion into home infusion signals a major shift toward decentralized, patient-centric care.

As utilities shift from AI pilots to enterprise-wide deployment, Bidgely's strategic leadership overhaul signals a calculated move to dominate the energy intelligence market.

Markel Canada appoints Marc Copland to scale its property division, leveraging AI and data to tackle complex risks and redefine the competitive landscape.